Breadcrumb Inicio IMPAACT News IMPAACT News News June 2026 Announcements Dr. Edmund Capparelli Honored with Award from ACCP March 2026 Announcements Call for Applications: Early Career Investigator Program 2026-2028 Cycle February 2026 Announcements IMPAACT at CROI 2026 Search Enter a search term. Filter Topics AllAnnouncementsMeetingsSpotlight SeriesStudy Results Date All20262025202420232022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 106 news items. August 2022 Spotlight Series Social Behavioral Scientific Core (SBSC) Spotlight Series: October 2022 July 2022 Meetings IMPAACT at International Workshop on HIV Pediatrics 2022 and AIDS 2022 July 2022 Announcements JIAS Special Issue: ‘Approaches to enhance and accelerate investigation of new HIV drugs in pregnancy’ April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV. March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children February 2022 Study Results IMPAACT Shares Study Results in CROI 2022 Oral Presentations February 2022 Study Results IMPAACT P1107 Team Presents First Known Case of a Woman with HIV Remission February 2022 Study Results IMPAACT Shares Study Results at CROI 2022 Poster Presentations January 2022 Meetings IMPAACT at CROI 2022 Pagination Previous page Prev Página 1 … Página 3 Página 4 Página 5 Página 6 Current page 7 Página 8 Página 9 Página 10 Página 11 Next page Next
July 2022 Announcements JIAS Special Issue: ‘Approaches to enhance and accelerate investigation of new HIV drugs in pregnancy’
April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV.
March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents
March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children
February 2022 Study Results IMPAACT P1107 Team Presents First Known Case of a Woman with HIV Remission
